Gamida Cell Ltd.
GMDADelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001600847
Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Gamida Cell Ltd. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 59 | 2 | 57 | 0 |
| Shares | 18.0M | 140.0K | 14.4M | −3.44M (−19.3%) |
| Value | $74.0M | $581.0K | $25.8M | −$47.7M (−64.9%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Gamida Cell Ltd. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 176,269 | $312.0K | 0.01% |
| Stock Yards Bank & Trust Co | 35,000 | $62.0K | 0.00% |
| Old National Bancorp | 32,081 | $57.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 23,902 | $42.0K | 0.00% |
| Virtu Financial LLC | 20,255 | $36.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,287 | $2.28K | 0.00% |
| Wagner Wealth Management, LLC | 63 | $0 | 0.00% |
| Aspire Private Capital, LLC | 200 | $0 | 0.00% |
Sold out (8)
Institutions that held Gamida Cell Ltd. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Laird Norton Trust Company, LLC | 529,103 | $2.19M |
| Citadel Advisors LLC | 32,577 | $135.0K |
| Ikarian Capital, LLC | 32,689 | $135.0K |
| Levin Capital Strategies, L.P. | 20,000 | $83.0K |
| Two Sigma Advisers, LP | 12,200 | $51.0K |
| Belvedere Trading LLC | 7,251 | $23.0K |
| UBS Group AG | 3,882 | $16.0K |
| Koshinski Asset Management, Inc. | 500 | $2.08K |
Not filed for Q2 2022 yet (2)
Institutions that held Gamida Cell Ltd. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 127,595 | $530.0K |
| Parametric Portfolio Associates LLC | 12,408 | $51.0K |